Lili Ataie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lili Ataie has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- MohammadReza Rahimi Shahmirzadi
Division of Infectious Diseases, Western University, London, Ontario, Canada
5 shared publications - Alp Sener
Department of Emergency Medicine, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkiye
2 shared publications - Danielle Ouellette
Division of Infectious Diseases, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 3K7, Canada
2 shared publications - Fabiana Kellen
Western University, Schulich School of Medicine, 1151 Richmond St, London, ON N6A 5C1, Canada
2 shared publications - Fatimah AlMutawa
Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 3K7, Canada
2 shared publications - Manal Y. Gabril
University Hospital
2 shared publications
Latest Publications
- 29 June 2026
- Published by University of Toronto Press Inc. (UTPress) in Journal of the Association of Medical Microbiology and Infectious Disease Canada
- Vol. 11 (2) , 196-204
Dual paradoxical reactions in tuberculous lymphadenitis during and after pregnancy: A case report
We report the case of a 23-year-old woman with tuberculous lymphadenitis diagnosed prior to pregnancy who developed paradoxical lymph node enlargement during pregnancy and again in the post-partum period. Despite completing a full 9-month course of standard anti-tuberculosis therapy, she experienced recurrent cervical lymphadenopathy and a transient pulmonary opacity following delivery. Extensive investigations, including repeat biopsies and cultures, excluded relapse or drug resistance, supporting the diagnosis of a paradoxical reaction. She was managed conservatively with drainage procedures, nonsteroidal anti-inflammatory drugs, and close monitoring, without the need for additional anti-tuberculosis medications or corticosteroids. Her lymphadenopathy resolved and she remained systemically well. This case is unique, as an extensive literature search in MEDLINE via PubMed and Embase from inception to September 2025 revealed no previously reported cases of paradoxical tuberculosis reactions occurring during pregnancy. This case underscores the importance of distinguishing paradoxical reactions from treatment failure, avoiding unnecessary therapy changes, and recognizing that conservative management is often sufficient in pregnancy and post-partum settings.
- 29 June 2026
- Published by University of Toronto Press Inc. (UTPress) in Journal of the Association of Medical Microbiology and Infectious Disease Canada
- Vol. 11 (2) , 196-204
Dual paradoxical reactions in tuberculous lymphadenitis during and after pregnancy: A case report
We report the case of a 23-year-old woman with tuberculous lymphadenitis diagnosed prior to pregnancy who developed paradoxical lymph node enlargement during pregnancy and again in the post-partum period. Despite completing a full 9-month course of standard anti-tuberculosis therapy, she experienced recurrent cervical lymphadenopathy and a transient pulmonary opacity following delivery. Extensive investigations, including repeat biopsies and cultures, excluded relapse or drug resistance, supporting the diagnosis of a paradoxical reaction. She was managed conservatively with drainage procedures, nonsteroidal anti-inflammatory drugs, and close monitoring, without the need for additional anti-tuberculosis medications or corticosteroids. Her lymphadenopathy resolved and she remained systemically well. This case is unique, as an extensive literature search in MEDLINE via PubMed and Embase from inception to September 2025 revealed no previously reported cases of paradoxical tuberculosis reactions occurring during pregnancy. This case underscores the importance of distinguishing paradoxical reactions from treatment failure, avoiding unnecessary therapy changes, and recognizing that conservative management is often sufficient in pregnancy and post-partum settings.
- Open Access
- 2 March 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (3) , 145
Concurrent Mold, Mycobacterial, and Viral Infections in a Hematopoietic Stem Cell Transplant Recipient Undergoing Lung Transplantation for Graft-Versus-Host Disease
Hematopoietic stem cell transplant (HSCT) recipients are at high risk for opportunistic infections due to profound immunosuppression and graft-versus-host disease (GvHD). Molds and nontuberculous mycobacteria (NTM) pose diagnostic and therapeutic challenges, especially when infections overlap. A 42-year-old woman with prior allogeneic HSCT for acute myeloid leukemia (AML) developed pulmonary infections with Microascus spp. and Mycobacterium chimaera, later complicated by Aspergillus calidoustus and RSV infection. Initial therapy included voriconazole, amphotericin B, and a macrolide-based multidrug regimen for NTM. Modifications were required for drug resistance and hepatotoxicity. Despite partial response, recurrent fungal infection necessitated prolonged antifungal therapy, including adjunctive inhaled amphotericin B and terbinafine. Ultimately, progressive bronchiolitis obliterans prompted bilateral lung transplantation. Explant pathology revealed necrotizing granulomas positive for NTM and Microascus spp. Post-transplant prophylaxis with voriconazole, rifabutin, azithromycin, and inhaled amikacin prevented recurrence, and the patient remained clinically stable at 6-month follow-up. This case illustrates the complexity of managing overlapping mold and NTM infections in HSCT recipients, highlighting the need for individualized, multidisciplinary care. Therapeutic drug monitoring, careful adjustment for drug–drug interactions, and the use of adjunctive inhaled antifungals were critical to achieving a favorable outcome.
- 2 March 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (3) , 145
Open AccessConcurrent Mold, Mycobacterial, and Viral Infections in a Hematopoietic Stem Cell Transplant Recipient Undergoing Lung Transplantation for Graft-Versus-Host Disease
Hematopoietic stem cell transplant (HSCT) recipients are at high risk for opportunistic infections due to profound immunosuppression and graft-versus-host disease (GvHD). Molds and nontuberculous mycobacteria (NTM) pose diagnostic and therapeutic challenges, especially when infections overlap. A 42-year-old woman with prior allogeneic HSCT for acute myeloid leukemia (AML) developed pulmonary infections with Microascus spp. and Mycobacterium chimaera, later complicated by Aspergillus calidoustus and RSV infection. Initial therapy included voriconazole, amphotericin B, and a macrolide-based multidrug regimen for NTM. Modifications were required for drug resistance and hepatotoxicity. Despite partial response, recurrent fungal infection necessitated prolonged antifungal therapy, including adjunctive inhaled amphotericin B and terbinafine. Ultimately, progressive bronchiolitis obliterans prompted bilateral lung transplantation. Explant pathology revealed necrotizing granulomas positive for NTM and Microascus spp. Post-transplant prophylaxis with voriconazole, rifabutin, azithromycin, and inhaled amikacin prevented recurrence, and the patient remained clinically stable at 6-month follow-up. This case illustrates the complexity of managing overlapping mold and NTM infections in HSCT recipients, highlighting the need for individualized, multidisciplinary care. Therapeutic drug monitoring, careful adjustment for drug–drug interactions, and the use of adjunctive inhaled antifungals were critical to achieving a favorable outcome.
- Open Access
- 1 January 2026
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 14
Pyoderma gangrenosum presenting to an infectious diseases clinic: A 2024 case series
Pyoderma gangrenosum is a rare neutrophilic dermatosis characterized by painful ulcerative skin lesions and a lack of definitive diagnostic tests. It is frequently mistaken for infectious conditions, often resulting in inappropriate antibiotic use and delayed immunosuppressive therapy. To describe the clinical and demographic characteristics of patients with pyoderma gangrenosum initially assessed in an infectious diseases setting and identify patterns that may aid in earlier diagnosis and management. A retrospective case series was conducted at a Cellulitis Clinic. Patients with a PARACELSUS score ⩾10 were included. Ten patients met inclusion criteria. Median age was 61.5 years; 60% were female and 90% Caucasian. Autoimmune diseases were present in 90%, mental health disorders in 50%, and endocrine abnormalities in 60%. Notably, 20% developed pyoderma gangrenosum at sites of healed scars—a rare presentation. Early recognition and multidisciplinary management are essential for timely treatment and improved outcomes.
- 1 January 2026
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 14
Open AccessPyoderma gangrenosum presenting to an infectious diseases clinic: A 2024 case series
Pyoderma gangrenosum is a rare neutrophilic dermatosis characterized by painful ulcerative skin lesions and a lack of definitive diagnostic tests. It is frequently mistaken for infectious conditions, often resulting in inappropriate antibiotic use and delayed immunosuppressive therapy. To describe the clinical and demographic characteristics of patients with pyoderma gangrenosum initially assessed in an infectious diseases setting and identify patterns that may aid in earlier diagnosis and management. A retrospective case series was conducted at a Cellulitis Clinic. Patients with a PARACELSUS score ⩾10 were included. Ten patients met inclusion criteria. Median age was 61.5 years; 60% were female and 90% Caucasian. Autoimmune diseases were present in 90%, mental health disorders in 50%, and endocrine abnormalities in 60%. Notably, 20% developed pyoderma gangrenosum at sites of healed scars—a rare presentation. Early recognition and multidisciplinary management are essential for timely treatment and improved outcomes.
- Open Access
- 12 August 2025
- Published by MDPI AG in Transplantology
- Vol. 6 (3) , 24
Biopsy-Proven Solid Organ Transplant Graft-Versus-Host Disease (SOT-GVHD) Involving the Skin, Liver, and Bone Marrow in a Simultaneous Kidney-Pancreas Transplant Recipient
Background: Graft-versus-host disease (GVHD) is a rare but serious complication following solid organ transplantation (SOT), particularly in transplants involving organs with a high volume of passenger donor T-lymphocytes. This case highlights the clinical course and diagnostic challenges of GVHD following simultaneous pancreas and pre-emptive kidney transplantation. Methods: A 51-year-old male with long-standing type 1 diabetes mellitus underwent simultaneous pancreas and kidney transplantation with induction therapy using rabbit anti-thymocyte globulin and methylprednisolone. Three months post-transplant, he presented with a diffuse lichenoid cutaneous eruption. Diagnostic evaluation included an extensive infectious workup, skin punch biopsy, liver and bone marrow biopsies, and microchimerism assay. Results: Skin biopsy revealed interface vacuolar dermatitis consistent with cutaneous GVHD. Subsequent liver and bone marrow biopsies confirmed GVHD involvement, with microchimerism assay showing 43% donor-origin T-cells in the bone marrow. Initial treatment with systemic and topical corticosteroids led to temporary improvement. However, the patient developed bone marrow suppression, recurrent bacteremia, and invasive fungal infection, resulting in a prolonged ICU stay and ultimately death. Conclusions: This case underscores the importance of considering SOT-GVHD in patients receiving organs rich in donor lymphocytes, such as pancreas transplants. Early recognition and multidisciplinary management are critical to improving outcomes in this rare but life-threatening condition.
- 12 August 2025
- Published by MDPI AG in Transplantology
- Vol. 6 (3) , 24
Open AccessBiopsy-Proven Solid Organ Transplant Graft-Versus-Host Disease (SOT-GVHD) Involving the Skin, Liver, and Bone Marrow in a Simultaneous Kidney-Pancreas Transplant Recipient
Background: Graft-versus-host disease (GVHD) is a rare but serious complication following solid organ transplantation (SOT), particularly in transplants involving organs with a high volume of passenger donor T-lymphocytes. This case highlights the clinical course and diagnostic challenges of GVHD following simultaneous pancreas and pre-emptive kidney transplantation. Methods: A 51-year-old male with long-standing type 1 diabetes mellitus underwent simultaneous pancreas and kidney transplantation with induction therapy using rabbit anti-thymocyte globulin and methylprednisolone. Three months post-transplant, he presented with a diffuse lichenoid cutaneous eruption. Diagnostic evaluation included an extensive infectious workup, skin punch biopsy, liver and bone marrow biopsies, and microchimerism assay. Results: Skin biopsy revealed interface vacuolar dermatitis consistent with cutaneous GVHD. Subsequent liver and bone marrow biopsies confirmed GVHD involvement, with microchimerism assay showing 43% donor-origin T-cells in the bone marrow. Initial treatment with systemic and topical corticosteroids led to temporary improvement. However, the patient developed bone marrow suppression, recurrent bacteremia, and invasive fungal infection, resulting in a prolonged ICU stay and ultimately death. Conclusions: This case underscores the importance of considering SOT-GVHD in patients receiving organs rich in donor lymphocytes, such as pancreas transplants. Early recognition and multidisciplinary management are critical to improving outcomes in this rare but life-threatening condition.
- Open Access
- 1 July 2025
- Published by MDPI AG in Preprints.org
Pancreas to Skin and Beyond: A Curious Case of Graft Versus Host Disease in a Kidney-Pancreas Transplant
A 51-year-old gentleman with complications from long-standing type 1 diabetes mellitus underwent simultaneous pancreas and pre-emptive kidney transplant at our center, with rabbit anti-thymocyte globulin and methylprednisolone induction. Three months post-transplant he presented for evaluation of a diffuse lichenoid cutaneous eruption. An extensive infectious workup was unrevealing, and skin punch biopsy showed interface vacuolar dermatitis, suggestive of graft-versus-host disease (GVHD) of the skin. The patient then developed acute transaminitis and neutropenia, and biopsies of the liver and bone marrow done subsequently also confirmed GVHD of these organs, with microchimerism assay on the bone marrow showing 43% of the T-cells were of donor origin. The patient improved with initiation of systemic and topical corticosteroids. Although a rare entity in solid organ transplantation, this case highlights the importance of considering solid organ transplant graft-versus-host disease (SOT-GVHD), particularly in patients receiving organs with a larger volume of passenger donor T-lymphocytes, such as is seen with intestinal, liver, and pancreas transplants.
- 1 July 2025
- Published by MDPI AG in Preprints.org
Open AccessPancreas to Skin and Beyond: A Curious Case of Graft Versus Host Disease in a Kidney-Pancreas Transplant
A 51-year-old gentleman with complications from long-standing type 1 diabetes mellitus underwent simultaneous pancreas and pre-emptive kidney transplant at our center, with rabbit anti-thymocyte globulin and methylprednisolone induction. Three months post-transplant he presented for evaluation of a diffuse lichenoid cutaneous eruption. An extensive infectious workup was unrevealing, and skin punch biopsy showed interface vacuolar dermatitis, suggestive of graft-versus-host disease (GVHD) of the skin. The patient then developed acute transaminitis and neutropenia, and biopsies of the liver and bone marrow done subsequently also confirmed GVHD of these organs, with microchimerism assay on the bone marrow showing 43% of the T-cells were of donor origin. The patient improved with initiation of systemic and topical corticosteroids. Although a rare entity in solid organ transplantation, this case highlights the importance of considering solid organ transplant graft-versus-host disease (SOT-GVHD), particularly in patients receiving organs with a larger volume of passenger donor T-lymphocytes, such as is seen with intestinal, liver, and pancreas transplants.